Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA (MRK)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
12/11/2017 12/12/2017 12/13/2017 12/14/2017 12/15/2017 Date
89.84(c) 91.16(c) 90.66(c) 90.05(c) 90.53(c) Last
438 582 450 143 371 912 461 183 860 995 Volume
+1.10% +1.47% -0.55% -0.67% +0.53% Change
More quotes
Financials (€)
Sales 2017 15 341 M
EBIT 2017 3 325 M
Net income 2017 1 658 M
Debt 2017 9 825 M
Yield 2017 1,40%
Sales 2018 15 573 M
EBIT 2018 3 173 M
Net income 2018 1 789 M
Debt 2018 7 859 M
Yield 2018 1,44%
P/E ratio 2017 20,48
P/E ratio 2018 20,55
EV / Sales2017 1,40x
EV / Sales2018 1,26x
Capitalization 11 700 M
More Financials
Company
Merck KGaA engages in the manufacturing of pharmaceutical and chemical products.It operates through the following segments: Healthcare, Life Science, and Performance Materials.The Healthcare segment comprises the businesses with prescription and over-the-counter pharmaceuticals and... 
Sector
Pharmaceuticals
Calendar
03/08Earnings Release
More about the company
Surperformance© ratings of Merck KGaA
Trading Rating : Investor Rating :
More Ratings
Latest news on MERCK KGAA
12/15 Germany's Merck in fresh bid to enter U.S. MS pill market
12/14 Perrigo lines up bid for Merck's consumer health unit - sources
12/13 MERCK : New Partnership to Fight Schistosomiasis in Ethiopia
12/12DJMERCK : Appoints Allan Gabor as Managing Director in China
12/12 MERCK : Allan Gabor Takes Over the Leadership of Merck KGaA, Darmstadt, Germany,..
12/11 REGENEUS LTD (ASX : RGS) Appoints Japan-Based Non-Executive Director with Extens..
12/11 MERCK : EMD Serono - John Walsh, M.D. Joins EMD Serono as Vice President of Neur..
12/11 MERCK : MilliporeSigma Signs Distribution Agreement with Avanti® Polar Lipids
12/10 REGENEUS LTD (ASX : RGS) Appoints Japan-Based Non-Executive Director with Extens..
12/07 MERCK : Darmstadt, Germany Receives Approval (Updated Registration) for Cladribi..
More news
Sector news : Specialty & Advanced Pharmaceuticals
12:38a PROCTER & GAMBLE : P&G appoints Peltz to board despite losing proxy battle
12:38a NELSON PELTZ : P&G appoints Peltz to board despite losing proxy battle
12/15 JAZZ PHARMACEUTICALS : Pennsylvania man admits to trading on tips about drug com..
12/15DJSTOCKS TO WATCH : CSX, Aclaris, Alnylam, Rigel
12/15 Germany's Merck in fresh bid to enter U.S. MS pill market
More sector news : Specialty & Advanced Pharmaceuticals
4-Traders Strategies on MERCK KGAA 
MERCK KGAA - 07/25
The downward trend should continue
SELL
MERCK KGAA - 2016
Towards the breakout of a major resistance level
BUY
More Strategies
News from SeekingAlpha
12/14 Perrigo to bid for German Merck's consumer health unit - Reuters
12/04 Merck KGaA's Mavenclad OK'd in Canada
12/01 Suitors preparing bids for Merck KgaA's consumer health unit
11/20 Roche Rocks On With More Good News
11/13 Orexigen Contrave up 10% on Contrave distribution deal with Merck KGaA for La..
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 108 €
Spread / Average Target 20%
EPS Revisions
Managers
NameTitle
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Crocifissa Attardo Member-Supervisory Board
Mechthild Auge Member-Supervisory Board
Michael Fletterich Vice Chairman-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA-9.18%13 747
ABBVIE55.46%153 511
KYOWA HAKKO KIRIN CO LTD33.44%11 113
JAZZ PHARMACEUTICALS PLC24.28%8 123
ZHANGZHOU PIENTZEHUANG PHARMACEUTICL LTD38.39%5 786
CONVATEC GROUP-13.13%5 322